empanelment of drug testing laboratories - Kerala Medical Services ...

More documents

Recommendations

Info

126 D14007/ Glycerine Magsulf Paste 50 Gram Bottle 380 12 B.P.C. 127 D04019 Glycopyrrolate Inj. 0.2mg/ml 1215 128 D17012 Haloperidol IP Inj 5mg/ml 1594 129 D17010 Haloperidol IP Tab 5 mg 683 130 D12003 Heparin Sodium IP Inj. 5000 I U/ml 2000 131 D12004 Heparin-Low Molecular Wt. Inj. 20mg/0.2ml 6900 132 D05002 Hydrocortisone Sodium Succinate IP Inj. 100 mg 1366 133 D01006 Ibuprofen I.P. Tab (Film Coated) 200mg 493 134 D01016 Ibuprofen I.P. Tab (Film Coated) 400 mg 493 135 D23001 Iohexol Inj 350mg/ml 1670 136 D04022 Isoflurane Liquid 100ml 350 137 D13001 Isosorbide Dinitrate I.P. Tab 5 mg 759 138 D13002 Isosorbide DinitrateI.P. Tab 10 mg 759 139 D01024 Keterolac Inj. 15 mg 580 140 D01025 Keterolac . Tab 10 mg 500 141 D20015 Lactulose Syrup 667mg/ ml 455 142 D04018 Lignocaine 2% with Adrenaline Inj. 1:200000 978 143 D04003 Lignocaine Hcl I.P. Gel 2% 638 144 D04005 Lignocaine HCL 5% (Heavy) I.P. Inj. 5% 638 145 D04004 Lignocaine HCL I.P. Inj. 2% w/v 622 146 D14024 Liquid Paraffin I.P 100 ml bottle 300 147 D17034 Lorazepam Inj. 2 mg 1438 148 D13011 Losartan Potassium Tab. 25 mg 1101 149 D16007 Magnesium Sulphate BP Inj. 500mg/ml 455 150 D18010 Mannitol I.P. Inj. 20%w/v 1366 151 D01014 Mefenamic Acid Tab 500 mg 607 152 D21003 Metformin IP Tab 500mg 607 153 D05012 Methyl Prednisolone Sodium Succinate I.P. 154 D05013 Methyl Prednisolone Sodium Succinate I.P. 155 D16004 Methylergometrin Maleate IP Inj 500 mg 1518 Inj 40 mg/ml 911 Inj. 200mcg/ ml 1063 156 D20005 Metoclopramide IP Inj. 5mg/ml 911 157 D20006 Metoclopramide IP Tab. 10mg 531 158 D13020 Metoprolol IP Tab 25mg 455 159 D13033 Metoprolol IP Tab 50 mg 455 KMSCL: EOI for Empanelment of Drug testing Laboratories Page 59
160 D02025 Metronidazole IP. Inj 5 mg/ml 1025 161 D02024 Metronidazole IP Tab 400 mg 319 162 D02023 Metronidazole IP Tab 200 mg 319 163 D07011 Midazolam Inj. 1 mg/ml 650 164 D06007 N-Acetyl Cysteine BP Inj 200 mg/ml 2277 165 D06003 Naloxone BP Inj. 400 mcg/ml 1670 166 D04008 Neostigmine Methyl Sulphate I.P. Inj 0.5 mg/ml 729 167 D13034 Nifedipine Retard Tab. 20 mg 500 168 D13006 Nifedipine Soft Gelatin 5 mg 531 Cap 169 D13005 Nifedipine IP Tab 10 mg 455 170 D13028 Nitroglycerin Inj 25 mg/5ml 1495 171 D02016 Norfloxacin I.P. Tab 400 mg 531 172 D02017 Ofloxacin Tab 200 mg 683 173 D20014 Ondansetron Inj 2mg/ml 1138 174 D20011/ ORS Powder I.P Powder Single dose sachet 683 12 175 D20018 Pantoprazole Inj. 40mg 650 176 D20020 Pantoprazole Tab. 20 mg 600 177 D01009 Paracetamol . Inj 150mg/2ml 607 178 D01022 Paracetamol Suppository 120mg 300 179 D01003 Paracetamol IP Syrup 125mg/5ml 683 180 D01002 Paracetamol I.P. Tab 500 mg. 531 181 D01008 Pentazocine LactateI.P. Inj. 30 mg/ml 873 182 D01007 Pethidine Hydrochloride I.P Inj 50 mg/ml 949 183 D05007 Pheniramine Maleate Tab 25 mg 531 184 D07003 Phenobarbitone Sodium IP Inj 200mg/ml 759 185 D07001 Phenobarbitone I.P. Tab 30 mg 524 186 D07002 Phenobarbitone I.P. Tab 60 mg 524 187 D07008 Phenytoin Sodium IP Inj 50 mg/ml 987 188 D07004 Phenytoin Sodium IP Tab 100 mg 531 189 D02039 PIPeracilline 4gm + Tazobactum 500 Mg Inj. 4.5gm 800 190 D18012 Pottasium Chloride I.P. Inj 10% w/v 1366 191 D14011 Povidone Iodine IP 5% W/V Solution 500ml 288 192 D14008 Povidone Iodine Ointment 5%w/w 266 193 D25004 Povidone Iodine Scrub 7.50% 205 194 D16006 Povidone Iodine Vaginal Pessaries 200 mg 288 195 D06004 Pralidoxime I.P. Inj 1 Gram 987 KMSCL: EOI for Empanelment of Drug testing Laboratories Page 60
Page 1 and 2:
KERALA MEDICAL SERVICES CORPORATION
Page 3 and 4:
SECTION I INTRODUCTION 1.1. The Ker
Page 5 and 6:
SECTION - II INVITATION OF EXPRESSI
Page 7 and 8:
2.16. The EOI Responder must submit
Page 9 and 10: 4.1 Time Limits Prescribed: SECTION
Page 11 and 12: 5.1 Contents of the EOI Document: S
Page 13 and 14: 5.4.10 A prospective offerer requir
Page 15 and 16: 5.7.4 It is also an opportunity for
Page 17 and 18: 5.10.17 Declaration in the Proforma
Page 19 and 20: opening of the envelopes before the
Page 21 and 22: 5.17.7 The availability of technica
Page 23 and 24: 5.22 Notification of Award/Letter o
Page 25 and 26: 5.24.6 Corporation will release the
Page 27 and 28: egard shall be in writing and the C
Page 29 and 30: testing fees at artificial non-comp
Page 31 and 32: 5.33.1 Nothing contained in this Co
Page 33 and 34: ANNEXURES KMSCL: EOI for Empanelmen
Page 35 and 36: EOI Cost EMD 12. Annexure VII - Det
Page 37 and 38: No.4.2.8 (Provide contact details l
Page 39 and 40: ANNEXURE- II (b) Ref. Clause No.5.1
Page 41 and 42: ANNEXURE-III Ref. Clause No.5.10.3
Page 43 and 44: PROFORMA FOR PERFORMANCE STATEMENT
Page 45 and 46: DECLARATION FORM ANNEXURE-VI Ref. C
Page 47 and 48: CONSENT LETTER OF THE OFFERER From,
Page 49 and 50: liability under this guarantee and
Page 51 and 52: And whereas the Laboratory has depo
Page 53 and 54: which bank details shall be furnish
Page 55 and 56: 14. In the event of any disputes be
Page 57 and 58: 39 D04017 Bupivacaine In Dextrose I
Page 59: 101 D18007/ Electrolyte P(Multi Inj
Page 63 and 64: 228 D03001 Theophylline and Etophyl
Page 65 and 66: 40 S27050 Endotracheal Tube 5.0 1 U
Page 67 and 68: 19 S27004 Hypo Allergic Acrylic Pap
Page 69 and 70: 25 S27572 26 S27531 27 S27574 28 S2
Page 71 and 72: DETAILS OF LABRATES FOR THE DRUGS A
Page 73 and 74: 45 D11006 Cabergoline tab Tab 0.5mg
Page 75 and 76: 88 D01028 Diclofenac sodium Gel Gel
Page 77 and 78: 126 D02074 Hpylori kit Each combi p
Page 79 and 80: 163 D04026 Lignocaine topical Spray
Page 81 and 82: 207 D24052 Octreotide Inj Inj 50 mc
Page 83 and 84: 255 D08028 Pyrantel Palmoate Syrup
Page 85: 302 D20037 Ursodeoxycholic Acid Tab
show all

empanelment of drug testing laboratories - Kerala Medical Services ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?